PUBLISHER: IMARC | PRODUCT CODE: 1746617
PUBLISHER: IMARC | PRODUCT CODE: 1746617
Japan peripheral vascular devices market size reached USD 548.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,016.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.6% during 2025-2033. The growing usage of minimally invasive surgeries, as they require shortened hospital stay and have faster recovery, is primarily driving the market growth.
Peripheral vascular disease (PVD) is a circulatory ailment resulting from the constriction, obstruction, or spasms in blood vessels situated outside the heart and brain. These occurrences lead to a diminished blood flow within these vessels, resulting in symptoms like weakness, discomfort, gangrene, leg hair loss, numbness, and muscle fatigue. To address artery blockages and narrowing, healthcare professionals utilize peripheral vascular devices, including angioplasty catheters, peripheral guidewires, vena cava filters, stent grafts, and embolic protection devices (EPD). Blockages in the peripheral vasculature, in particular, are primarily caused by the accumulation of plaque, which constricts the blood vessels and hampers blood circulation to various body regions. Peripheral vascular devices are a secure solution that minimizes the risk of infection and irritation while enhancing blood flow and supplying oxygen-rich blood through the arteries.
The Japan peripheral vascular disease market is experiencing a promising trajectory, primarily due to the escalating prevalence of venous diseases, including chronic venous insufficiency (CVI) on a global scale. Peripheral vascular devices play a pivotal role in ensuring adequate blood flow to critical regions like the brain, legs, and feet, thus enabling optimal bodily functions. Contributing to this upward trend is the growing aging population in Japan and the surging incidence of various conditions such as peripheral artery disease (PAD) and arterial blockages. Lifestyle factors, including smoking, excessive alcohol consumption, physical inactivity, and unhealthy dietary choices, have played a significant role in these health issues. The market is further bolstered by the increasing preference for minimally invasive surgeries (MIS), driven by their advantages such as reduced complications, decreased postoperative discomfort, shorter hospital stays, and quicker recovery times. Additionally, the widespread adoption of atherectomy devices is on the rise due to the increasing prevalence of atherosclerosis, obesity, and lifestyle-related disorders. The healthcare sector in Japan is witnessing substantial growth, with consumers having greater spending capacity and increased investment in research and development (R&D) activities. These factors collectively contribute to a positive outlook for the Japan peripheral vascular disease market, ensuring its continued growth and development, over the forecasted period.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.